# Siegfried Hameln GmbH – FDA Inspection, Jun 14, 2012

Source: https://www.keypedia.com/records/fda_inspections/siegfried-hameln-gmbh/ee325421-5a50-4446-ab22-7f225fce421f
Source feed: FDA_Inspections

> FDA inspection 786813 of Siegfried Hameln GmbH, June 14, 2012. Classification: Official Action Indicated (OAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 786813
- Company Name: Siegfried Hameln GmbH
- Inspection Date: 2012-06-14
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1203347 - 2022-09-01
- [FDA Inspection 1050123 - 2018-04-24](https://www.keypedia.com/records/fda_inspections/siegfried-hameln-gmbh/e042aba9-c4b7-422c-b3eb-1a852022bb80)
- FDA Inspection 987428 - 2016-07-01
- [FDA Inspection 887446 - 2014-07-25](https://www.keypedia.com/records/fda_inspections/siegfried-hameln-gmbh/098b0d0c-6d3f-4682-8290-157ece943b50)
- FDA Inspection 637807 - 2009-11-09

Company: https://www.keypedia.com/companies/siegfried-hameln-gmbh/f6010d3b-48cd-40df-ad2f-b13fa57fca0b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c